Journey Medical

Journey Medical

Pharmaceuticals
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

$93.2M

Market Cap • 11/20/2026

2014

(12 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

2,9

P/S

1,3

P/EBITDA

42,1

P/OCF

—

P/FCF

—

P/E

—

BVPS

1,1

EPS

—

Market Cap

Market Cap

93,2M

EV

96,5M

EV/Revenue

1,4

EV/EBITDA

43,6

EV/EBIT

-48

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-6,4%

Total Yield

-6,4%

Payout

0%

Retained Earnings

-102,3M

Profitability

Gross Margin

65,9%

EBITDA Margin

3,2%

EBIT Margin

—

Net Margin

—

D&A/EBITDA

186,6%

R&D/Revenue

0,4%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

—

% PPE

0%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

3,2%

CAGR Op. Income 5Y

-38,2%

CAGR Net Income 5Y

-27,5%

CAGR EPS 5Y

-39,4%

Leverage

N.D./EBITDA

1,5

Debt/Equity

0%

Current Ratio

1,5

Quick Ratio

1,3

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium